Get startedLog in
    Picture of Prophase Labs logo

    PRPH — Prophase Labs News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: Impact Biomedical Announces License Agreement With Prophase Labs To Produce And Distribute Viral-Fighting Compound Equivir

    Picture of Prophase Labs logoProphase Labs
    28/06/2022 13:25
    June 28 (Reuters) - DSS Inc  DSS.A :
    * IMPACT BIOMEDICAL ANNOUNCES LICENSE AGREEMENT WITH
PROPHASE LABS
TO PRODUCE AND DISTRIBUTE VIRAL-FIGHTING COMPOUND EQUIVIR

Source text for Eikon:  ID:nGNX2MW6mY 
Further company coverage:  DSS.A

    Recent news on Prophase Labs

    See all news